MUTIERTE IMMUNGLOBULINBINDENDE POLYPEPTIDE

Patent europeic · EP3757123 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3757123
Numer da la dumonda
EP20185632
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
16-11-2015
Publitgà
30-12-2020
Concedì
21-08-2024
La protecziun finescha il pli tard
15-11-2035
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
C07K 16/06 (2006.01)
C07K 1/22 (2006.01)
Prioritad
SE 1451376 17.11.2014
GB 201510261 12.06.2015
GB 201510263 12.06.2015
Derivà da
EP15797940
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 02-07-2025

    Midada

    Published in Swissreg on 02.07.2025

  3. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  4. 27-08-2024

    Represchentant inscrit

    Representative
    VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 27.08.2024

  5. 21-08-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 21.08.2024

Partidas

Possessur

Cytiva BioProcess R&D AB

Björkgatan 30, 751 84 Uppsala, SE

Represchentant

VALIPAT c/o BOVARD LTD

Optingenstrasse 16, 3013 Bern

Inventur

RODRIGO, Gustav

751 84 Uppsala, SE

BJORKMAN, Tomas

751 84 Uppsala, SE

ANDER, Mats

751 84 Uppsala, SE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.